sanofi-aventis, Chattem Inc., KaloBios deal

sanofi-aventis' Sanofi Pasteur S.A. vaccines division received exclusive, worldwide rights to develop and commercialize KaloBios'

Read the full 150 word article

How to gain access

Continue reading with a
two-week free trial.